Austin Regional Clinic Physicians constantly tries to improve the care given to you and to all our patients. We are dedicated to offering unique options for our patients to help them reach ideal health goals. Part of this dedication involves making clinical research available. Clinical research makes it possible to discover the benefits, risks, and safety of both commercially-available and investigational medications.
Research standards are very strict to help make studies as safe as possible. Each study we conduct has already been reviewed by teams of government and research experts to minimize any study risks. Austin Regional Clinic has decided to be involved in this research study because we think it can potentially benefit our patients.
Meningococcal disease refers to any illness caused by the bacteria Neisseria meningitides. This includes Meningitis, an infection of the brain/spinal cord and Septicemia, an infection of the bloodstream. Both are very serious and can become deadly in a matter of hours. If left untreated, meningococcal disease can lead to deafness, brain damage, or can even be fatal.
- High temperature
- Less or no interest in eating
- Too lethargic to wake up
- Difficulty breathing
- Stiff, jerky movements or floppiness
- Rash covering the body that does not fade under pressure
Meningococcal disease is easily spread and can affect all age groups. However, infants under one, adolescents, and young adults are considered some of the most at-risk groups. The most effective way to protect against meningococcal disease is vaccination. As of now, most meningococcal vaccines target older age groups. Since infants under the age of one are among the most at risk, there is an unmet need for meningococcal vaccines that provide protection to that youngest age group.
If you’d like to see if you qualify, please contact our research team. You can call our ARC Clinical Research team at 512-225-5931, or fill out our Clinical Research interest form online.
What to Expect
We are currently seeking candidates for a paid clinical research study at Austin Regional Clinic Wilson Parke.
- Enroll as infants between ages of ≥ 42 to ≤ 89 days
- Receive other standard vaccines in addition to meningococcal vaccine
# Visit's Required:
Request to Participate